Publicaciones en colaboración con investigadores/as de University of Massachusetts Medical School (13)

2023

  1. JNKs protect from cholestatic liver disease progression by modulating Apelin signalling

    JHEP Reports, Vol. 5, Núm. 11

2022

  1. Activation of the unfolded protein response (Upr) is associated with cholangiocellular injury, fibrosis and carcinogenesis in an experimental model of fibropolycystic liver disease

    Cancers, Vol. 14, Núm. 1

2021

  1. Differential role of MLKL in alcohol-associated and non-alcohol-associated fatty liver diseases in mice and humans

    JCI Insight, Vol. 6, Núm. 4

2020

  1. JNK-mediated disruption of bile acid homeostasis promotes intrahepatic cholangiocarcinoma

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 117, Núm. 28, pp. 16492-16499

  2. Loss of c-Jun N-terminal Kinase 1 and 2 Function in Liver Epithelial Cells Triggers Biliary Hyperproliferation Resembling Cholangiocarcinoma

    Hepatology Communications, Vol. 4, Núm. 6, pp. 834-851

2018

  1. Patients with CD3G mutations reveal a role for human CD3g in Treg diversity and suppressive function

    Blood, Vol. 131, Núm. 21, pp. 2335-2344

2017

  1. C-Jun N-terminal kinase 2 promotes enterocyte survival and goblet cell differentiation in the inflamed intestine

    Mucosal Immunology, Vol. 10, Núm. 5, pp. 1211-1223

2016

  1. Combined Activities of JNK1 and JNK2 in Hepatocytes Protect Against Toxic Liver Injury

    Gastroenterology, Vol. 150, Núm. 4, pp. 968-981

2015

  1. Bone marrow-derived c-jun N-terminal kinase-1 (JNK1) mediates liver regeneration

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1852, Núm. 1, pp. 137-145

  2. Haematopoietic cell-derived Jnk1 is crucial for chronic inflammation and carcinogenesis in an experimental model of liver injury

    Journal of Hepatology, Vol. 62, Núm. 1, pp. 140-149

2014

  1. Jnk1 in murine hepatic stellate cells is a crucial mediator of liver fibrogenesis

    Gut, Vol. 63, Núm. 7, pp. 1159-1172

2005

  1. Antiviral chemotherapy facilitates control of poxvirus infections through inhibition of cellular signal transduction

    Journal of Clinical Investigation, Vol. 115, Núm. 2, pp. 379-387

2004

  1. Biochemical and functional analysis of smallpox growth factor (SPGF) and anti-SPGF monoclonal antibodies

    Journal of Biological Chemistry, Vol. 279, Núm. 24, pp. 25838-25848